Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease

by Mari Aksnes, Ann Tiiman, Trine Holt Edwin, Trine Holt Edwin, Trine Holt Edwin, Lars Terenius, Nenad Bogdanović, Vladana Vukojević, Anne-Brita Knapskog
Published 2021-01-01

Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis.

by Marit Mjørud, Geir Selbæk, Espen Bjertness, Trine Holt Edwin, Knut Engedal, Anne-Brita Knapskog, Bjørn Heine Strand
Published 2020-01-01

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease

by Mari Aksnes, Hans Christian D. Aass, Ann Tiiman, Trine Holt Edwin, Lars Terenius, Nenad Bogdanović, Vladana Vukojević, Anne-Brita Knapskog
Published 2021-06-01

Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic.

by Ebba Gløersen Müller, Trine Holt Edwin, Caroline Stokke, Sigrid Stensby Navelsaker, Almira Babovic, Nenad Bogdanovic, Anne Brita Knapskog, Mona Elisabeth Revheim
Published 2019-01-01

Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway.

by Bjørn Heine Strand, Anne-Brita Knapskog, Karin Persson, Trine Holt Edwin, Rachel Amland, Marit Mjørud, Espen Bjertness, Knut Engedal, Geir Selbæk
Published 2018-01-01

A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease

by Trine Holt Edwin, Kristi Henjum, Lars N.G. Nilsson, Leiv Otto Watne, Karin Persson, Rannveig Sakshaug Eldholm, Ingvild Saltvedt, Nathalie Bodd Halaas, Geir Selbæk, Knut Engedal, Bjørn Heine Strand, Anne‐Brita Knapskog
Published 2020-01-01